JP2013544799A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544799A5
JP2013544799A5 JP2013535215A JP2013535215A JP2013544799A5 JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5 JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
compound
pharmaceutical composition
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013535215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544799A (ja
JP6007186B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2011/001179 external-priority patent/WO2012097427A1/en
Publication of JP2013544799A publication Critical patent/JP2013544799A/ja
Publication of JP2013544799A5 publication Critical patent/JP2013544799A5/ja
Application granted granted Critical
Publication of JP6007186B2 publication Critical patent/JP6007186B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013535215A 2010-10-27 2011-10-26 がん治療のための化合物および組成物 Expired - Fee Related JP6007186B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40706910P 2010-10-27 2010-10-27
US61/407,069 2010-10-27
PCT/CA2011/001179 WO2012097427A1 (en) 2010-10-27 2011-10-26 Compounds and compositions for the treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016153378A Division JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Publications (3)

Publication Number Publication Date
JP2013544799A JP2013544799A (ja) 2013-12-19
JP2013544799A5 true JP2013544799A5 (enExample) 2014-12-11
JP6007186B2 JP6007186B2 (ja) 2016-10-12

Family

ID=46515034

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013535215A Expired - Fee Related JP6007186B2 (ja) 2010-10-27 2011-10-26 がん治療のための化合物および組成物
JP2016153378A Expired - Fee Related JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016153378A Expired - Fee Related JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Country Status (24)

Country Link
US (2) US9114118B2 (enExample)
EP (2) EP3443957B1 (enExample)
JP (2) JP6007186B2 (enExample)
KR (2) KR101821646B1 (enExample)
CN (2) CN105997967B (enExample)
AU (2) AU2011356583C1 (enExample)
BR (1) BR112013010507A2 (enExample)
CA (1) CA2816093C (enExample)
CL (1) CL2013001152A1 (enExample)
DK (2) DK3443957T3 (enExample)
EA (2) EA035494B1 (enExample)
ES (2) ES2837599T3 (enExample)
IL (2) IL225599A (enExample)
MX (2) MX365807B (enExample)
MY (2) MY162420A (enExample)
NZ (1) NZ610851A (enExample)
PH (2) PH12013500766B1 (enExample)
PL (2) PL2632452T3 (enExample)
PT (2) PT3443957T (enExample)
SG (2) SG10201807622WA (enExample)
TR (1) TR201819987T4 (enExample)
TW (2) TWI620563B (enExample)
WO (1) WO2012097427A1 (enExample)
ZA (1) ZA201303035B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105997967B (zh) * 2010-10-27 2019-08-23 普罗米蒂克医药Smt有限公司 用于治疗癌症的化合物和组合物
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
US20150250717A1 (en) 2014-03-06 2015-09-10 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder cancer with gemcitabine
RU2560702C1 (ru) * 2014-06-05 2015-08-20 Общество с ограниченной ответственностью "Научно-производственный центр "Амфион" (ООО "НПЦ "Амфион") Фармацевтическая композиция для применения в онкологии
PL3203999T3 (pl) * 2014-10-10 2020-07-27 Liminal Biosciences Limited Podstawione związki aromatyczne i kompozycje farmaceutyczne do zapobiegania i leczenia osteoporozy
WO2016054725A1 (en) * 2014-10-10 2016-04-14 Prometic Biosciences Inc. Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
AU2015345943B2 (en) 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
CN106267213A (zh) * 2015-05-27 2017-01-04 聊城市奥润生物医药科技有限公司 环二核苷酸cGAMP在治疗肿瘤联合用药中的应用
US10857173B2 (en) 2017-07-25 2020-12-08 Taris Biomedical Llc Methods of treating tumor metastasis
JOP20200124A1 (ar) 2017-11-08 2020-05-20 Taris Biomedical Llc طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك
EP3890717A4 (en) * 2018-12-05 2022-08-24 Liminal Biosciences Limited USE OF SODIUM 2-(3-PENTYLPHENYL)ACETATE IN THE TREATMENT OF ALSTRÖM SYNDROME
US11246945B2 (en) 2019-06-07 2022-02-15 National Defense Medical Center Cisplatin-loaded microbubbles, pharmaceutical composition for treatment of cancer, method for preparing pharmaceutical compositions and method for treating cancer
EP4003314B1 (en) 2019-07-26 2024-07-10 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids useful for the prevention or treatment of disease
AU2021356346A1 (en) * 2020-10-06 2023-06-15 Pharmaceutique Ingenew Inc. Substituted aromatic compounds and pharmaceutical compositions thereof
AU2022209835B2 (en) 2021-01-25 2026-05-21 Espervita Therapeutics, Inc. Functionalized long-chain carboxylic acids, and their use for treatment of disease
CN114436822B (zh) * 2022-01-12 2024-04-16 厦门稀土材料研究所 一枝蒿酮酸和生物碱复盐及其制备方法和用途
AU2024239546A1 (en) * 2023-03-22 2025-10-02 Uti Limited Partnership Hydroxyphenyl propanoate compounds for tumour immunotherapy, compositions and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268907A3 (en) * 1986-11-19 1990-03-21 Carl Richard Thornfeldt Treatment of disease conditions relating to hyperactive organelles
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
ITMI20012434A1 (it) * 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
CN1169768C (zh) * 2002-04-26 2004-10-06 中国科学院上海有机化学研究所 (4-炔基)-芳香酮酸类化合物、合成方法及应用
CA2506897A1 (en) * 2002-12-27 2004-07-15 Tibotec Bvba Fluorogenic enzyme substrates and methods of preparation
WO2005010202A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS
WO2005009104A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
US8198328B2 (en) * 2004-01-21 2012-06-12 New York University Treatment of cancer using benzoic acid derivatives
US20100010002A1 (en) 2006-09-01 2010-01-14 Piramal Life Sciences Limited Anticancer use of caffeic acid and its derivatives
CN101616583A (zh) * 2007-02-08 2009-12-30 爱密斯菲尔科技公司 苯烷基羧酸输送剂
WO2009055932A1 (en) * 2007-11-02 2009-05-07 Prometic Biosciences Inc. Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis
US9532962B2 (en) * 2007-11-02 2017-01-03 Prometic Pharma Smt Limited Medium-chain length fatty acids and glycerides as nephroprotection agents
JP5473937B2 (ja) 2007-12-19 2014-04-16 プロメティック・バイオサイエンシーズ・インコーポレイテッド 膵臓癌の治療のためのゲムシタビンと併用した中鎖脂肪酸、その塩およびトリグリセリド
EP2427416B1 (en) * 2009-05-04 2016-03-09 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical uses thereof
BRPI1015118A2 (pt) * 2009-05-04 2016-04-12 Prometic Biosciences Inc sais de ácido pentilfenilacético e usos farmacêuticos dos mesmos
CN105997967B (zh) * 2010-10-27 2019-08-23 普罗米蒂克医药Smt有限公司 用于治疗癌症的化合物和组合物

Similar Documents

Publication Publication Date Title
NZ610851A (en) Compounds and compositions for the treatment of cancer
JP2014528467A5 (enExample)
JP2014513704A5 (enExample)
JP2013507423A5 (enExample)
JP2018507197A5 (enExample)
MX2009004715A (es) Compuestos heterociclicos como agentes antiinflamatorios.
JP2016503414A5 (enExample)
GEP20115174B (en) Triazolopyrazine derivatives useful as anti-cancer agents
JP2013510860A5 (enExample)
JP2008535902A5 (enExample)
JP2015522650A5 (enExample)
JP2006504624A5 (enExample)
JP2019529518A5 (enExample)
JP2014528466A5 (enExample)
JP2009543802A5 (enExample)
NZ710745A (en) Pyrrolobenzodiazepines and conjugates thereof
SI2970216T1 (en) Biaryl-amide compounds as kinase inhibitors
JP2012505871A5 (enExample)
JP2015531366A5 (enExample)
JP2008535903A5 (enExample)
JP2011251990A5 (enExample)
JP2009536221A5 (enExample)
JP2014518882A5 (enExample)
GEP201606540B (en) New indolizine derivatives, method for their preparation and pharmaceutical compositions containing thereof
JP2014524441A5 (enExample)